Prosecution Insights
Last updated: July 17, 2026

Quarles & Brady LLP (Northwestern)

41 pending office actions • 12 clients • 41 examiners • 32 art units • 0 of 41 (0%) have an AI response strategy ready • 34 patents granted in the last 365 days

Quality Metrics (n=903 apps, methodology: how we score firms)

90.3%
Allowance Rate
n=903
+0.94σ
Allowance Rate (norm)
n=903
3.5
OAs to Allowance
n=372
-0.20σ
OAs to Allow (norm)
n=372
1096 days
Time to Allowance
n=372
+9.0pp
Interview Lift
n=903
31.1%
RCE Rate
n=903
1.8%
Appeal Rate
n=903

Rejection Performance (% of received rejections ultimately overcome)

§101 Overcome
n=10 (min 20)
78.7%
§102 Overcome
n=94
73.2%
§103 Overcome
n=231
84.0%
§112 Overcome
n=94

Specialization & Scale

A61K, A61P, C07D
Top CPC Subclasses
37%
Top-3 CPC Share
n=903
0
Practitioners
n=903
Apps / Practitioner
n=903 (min 20)

Portfolio Summary

41
Total Pending OAs
27
Non-Final OAs
12
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 18 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

10
Overdue
0
Due this week
8
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 18 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (10)Due ≤ 30 days (8)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
33
Medium (80%)
6
Easy (15%)
2
Unknown (5%)

Rejection Statute Mix

BucketCases
§103 only25 (61%)
§102 only8 (20%)
§112 only3 (7%)
Double-patenting only3 (7%)
No statute on record2 (5%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

38
Life Sciences
93% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
5% of docket
1
Business / Other
2% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

410 h
Manual time on pending OAs
82 h
Time saved (low, 20%)
144 h
Time saved (mid, 35%)
3.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
POPESCU, GABRIEL VICTOR 1 63.3% +30.5%
SCHLEIS, DANIEL J 1 71.5% +5.2%
JACKSON, SHAWQUIA 1 78.0% -3.4%
ROSENTHAL, ANDREW S 1 51.4% +40.6%
ARMSTRONG, SUSANNAH SIPPLE 1 32.0% +46.7%
CORNET, JEAN P 1 42.0% +47.6%
SHOWALTER, ALEXANDER KEITH 1 54.9% +50.7%
GALSTER, SAMUEL LEONARD 1 53.2% +40.6%
KINSEY WHITE, NICOLE ERIN 1 57.9% +16.3%
TOWNSLEY, SARA ELIZABETH 1 25.1% +48.7%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18512950 Small Molecule Degraders of DOT1L and Uses Thereof TOWNSLEY, SARA ELIZABETH

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19215178 INFRARED THERMOGRAPHY FOR INTRAOPERATIVE FUNCTIONAL MAPPING POPESCU, GABRIEL VICTOR
18694853 NANOPARTICULATE MONOBENZONE FOR TREATING MELANOMA ROSENTHAL, ANDREW S
18691863 LIPIODOL FORMULATION FOR TRANSARTERIAL CHEMOIMMUNOEMBOLIZATION ARMSTRONG, SUSANNAH SIPPLE
18434367 MODULATION OF SEX STEROID HORMONE PRODUCTION AND ACTIVITY FOR TREATING AND PREVENTING HERNIAS CORNET, JEAN P
18006688 CLOTRIMAZOLE AS A TREATMENT FOR IMMUNODEFICIENCY DISORDERS SHOWALTER, ALEXANDER KEITH
18391200 METHODS AND COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS CLASS I MUTATIONS GALSTER, SAMUEL LEONARD
18515196 TGF-BETA INHIBITION FOR IMMUNODEFICIENCY VIRUS REACTIVATION FROM LATENCY, ENHANCEMENT OF IMMUNODEFICIENCY VIRUS-SPECIFIC RESPONSES AND IMMUNODEFICIENCY VIRUS CURE KINSEY WHITE, NICOLE ERIN
18512950 Small Molecule Degraders of DOT1L and Uses Thereof TOWNSLEY, SARA ELIZABETH

Client Portfolio (12 clients)

Top Art Units

Art UnitApps
16293
16933
16912
16822
16712
16472
37971
17841
16131
16161

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19215178 INFRARED THERMOGRAPHY FOR INTRAOPERATIVE FUNCTIONAL MAPPING Northwestern University POPESCU, GABRIEL VICTOR 3797 Non-Final OA Pending May 21, 2025
18880219 REACTIVE OXYGEN SPECIES RESPONSIVE CLEAVABLE HIERARCHIAL METALLIC SUPRANANOSTRUCTURES Northwestern University SCHLEIS, DANIEL J 1784 §102 Non-Final OA Pending Dec 30, 2024
18821660 USE OF NEURONAL NITRIC OXIDE SYNTHASE INHIBITORS FOR IMMUNOTHERAPY IN MELANOMA PATIENTS Chapman University JACKSON, SHAWQUIA DP Non-Final OA Pending Aug 30, 2024
18694853 NANOPARTICULATE MONOBENZONE FOR TREATING MELANOMA Northwestern University ROSENTHAL, ANDREW S 1613 §103 Final Rejection Pending Mar 22, 2024
18691863 LIPIODOL FORMULATION FOR TRANSARTERIAL CHEMOIMMUNOEMBOLIZATION Northwestern University ARMSTRONG, SUSANNAH SIPPLE 1616 §103 Non-Final OA Pending Mar 13, 2024
18434367 MODULATION OF SEX STEROID HORMONE PRODUCTION AND ACTIVITY FOR TREATING AND PREVENTING HERNIAS Northwestern University CORNET, JEAN P 1628 §103 Non-Final OA Pending Feb 06, 2024
18006688 CLOTRIMAZOLE AS A TREATMENT FOR IMMUNODEFICIENCY DISORDERS Northwestern University SHOWALTER, ALEXANDER KEITH 1629 §103 Non-Final OA Pending Jan 23, 2024
18391200 METHODS AND COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS CLASS I MUTATIONS Ann & Robert H. Lurie Children's Hospital of Chicago GALSTER, SAMUEL LEONARD 1693 DP Non-Final OA Pending Dec 20, 2023
18515196 TGF-BETA INHIBITION FOR IMMUNODEFICIENCY VIRUS REACTIVATION FROM LATENCY, ENHANCEMENT OF IMMUNODEFICIENCY VIRUS-SPECIFIC RESPONSES AND IMMUNODEFICIENCY VIRUS CURE Northwestern University KINSEY WHITE, NICOLE ERIN 1672 Non-Final OA Pending Nov 20, 2023
18512950 Small Molecule Degraders of DOT1L and Uses Thereof Northwestern University TOWNSLEY, SARA ELIZABETH 1629 §112 Non-Final OA Pending Nov 17, 2023
18467698 NEDDYLATION INHIBITION FOR USE IN THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION Northwestern University FOWLER, ALAN JEROME 1691 §103 Non-Final OA 37d overdue Pending Sep 14, 2023
18466599 RATIONAL DESIGN, OPTIMIZATION, AND BIOLOGICAL EVALUATION OF NOVEL MEK4 INHIBITORS AGAINST PANCREATIC ADENOCARCINOMA Northwestern University CHEN, PO-CHIH 1621 §103 Final Rejection Pending Sep 13, 2023
18465749 HIERARCHICAL NANOPOROUS DIAMONDOID SUPERSTRUCTURE King Abdulaziz City For Science And Technology JARRELL, NOBLE E 1699 §102 Non-Final OA 22d Pending Sep 12, 2023
18548784 (S)-3-AMINO-4,4-DIHALOCYCLOPENT-1-ENECARBOXYLIC ACID AS SELECTIVE INACTIVATORS OF HUMAN ORNITHINE AMINOTRANSFERASE Northwestern University CHICKS, ASHLI ARIANA 1626 §103 Non-Final OA 13d Pending Sep 01, 2023
18548175 CELL-FREE BIOSENSORS WITH DNA STRAND DISPLACEMENT CIRCUITS Northwestern University SALMON, KATHERINE D 1682 DP Non-Final OA Pending Aug 28, 2023
18330874 INHIBITORS OF THE INTERACTION BETWEEN TRIP8B AND HCN CHANNELS AND USES THEREOF FOR TREATING NEUROLOGICAL DISEASES AND DISORDERS Northwestern University SAWYER, JENNIFER C 1691 §102 Non-Final OA 2d overdue Pending Jun 07, 2023
18328967 Portable Closed System for Culturing Cells Using Small Volumes of Capillary Blood Northwestern University LEPAGE, JONATHAN EVERETT 1796 §103 Non-Final OA Pending Jun 05, 2023
18251604 A CELL-FREE BIO-MANUFACTURING PLATFORM FOR PRODUCTION OF FATTY ACIDS AND CANNABINOIDS Northwestern University RAMIREZ, DELIA M 1652 §102 Non-Final OA Pending May 03, 2023
18251596 METHODS FOR FULL-LENGTH REVERSE TRANSCRIPTION PCR OF LONG RNAs CONTAINING MODIFIED RIBONUCLEOSIDES USING A THERMOSTABLE REVERSE TRANSCRIPTASE Northwestern University GREENE, CAROLYN LEE 1681 §103 Non-Final OA Pending May 03, 2023
18308349 METHODS FOR IMPROVING COVID VACCINE IMMUNOGENICITY Northwestern University TANG, JIANMING 1671 §102 Non-Final OA 46d overdue Pending Apr 27, 2023
18249057 USE OF REELIN FOR TREATING CARDIAC DISEASES Northwestern University BUTTICE, AUDREY L 1647 §103 Non-Final OA 16d overdue Pending Apr 13, 2023
18040888 METHODS OF TREATING MALIGNANT GLIOBLASTOMA The Trustees of Columbia University in the City of New York STOICA, ELLY GERALD 1647 §103 Final Rejection 22d Pending Feb 07, 2023
18005826 ENGINEERED N-GLYCOSYLTRANSFERASES WITH ALTERED SPECIFICITIES Northwestern University EIX, EMILY FAY 1653 §103 Final Rejection Pending Jan 17, 2023
18004104 HUMAN RECOMBINANT ACE2-FC MUTANTS THAT DECOUPLE ANTI-SARS-COV-2 ACTIVITY FROM CARDIOVASCULAR EFFECTS Northwestern University NIEBAUER, RONALD T 1658 §103 Final Rejection Pending Jan 03, 2023
18003911 A SINGLE PATIENT CLASSIFIER FOR T1 HIGH GRADE BLADDER CANCER Dxige Research, Inc. STUBBS, JOHN THOMAS 1686 §103 Non-Final OA Pending Dec 29, 2022
18002940 METHODS AND COMPOSITIONS FOR THE TREATMENT OF COVID-19 AND ASSOCIATED RESPIRATORY DISTRESS AND MULTI-ORGAN FAILURE, SEPSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, AND CARDIOVASCULAR DISEASES Ann & Robert H. Lurie Children's Hospital of Chicago WELLS, LAUREN QUINLAN 1622 §103 Final Rejection 56d overdue Pending Dec 22, 2022
18002457 PROCESS FOR DIRECT READOUT OF IMMUNOGLOBULINS Northwestern University XU, XIAOYUN 1797 §103 Final Rejection 28d Pending Dec 19, 2022
18058419 RNA-DIRECTED DNA CLEAVAGE AND GENE EDITING BY CAS9 ENZYME FROM NEISSERIA MENINGITIDIS Wisconsin Alumni Research Foundation GROOMS, TIFFANY NICOLE 1637 §103 Final Rejection Pending Nov 23, 2022
17997013 Small Molecule Inhibitors That Block the Budding of Enveloped Viruses Northwestern University MCDOWELL, BRIAN E 1624 §103 Non-Final OA 15d Pending Oct 24, 2022
18048673 A SYNTHENTIC POLY-TRANSTHYRETIN AFFINITY TRAP FOR DETECTING AMYLOIDOGENIC TRANSTHYRETIN FORMS IN PLASMA SAMPLES OFTRANTHYRETIN AMYLOIDOSIS PATIENTS Northwestern University DUNN, MCKENZIE A 1678 §103 Final Rejection Pending Oct 21, 2022
17907374 MECHANICAL-BOND-PROTECTED STABLE BISRADICALS Northwestern University TRAN, ERIC 1629 §112 Non-Final OA Pending Sep 26, 2022
17932320 NON-NEUROINVASIVE VIRUSES AND USES THEREOF Trustees Of Tufts College (Aka Tufts University) LI, BAO Q 1671 §112 Non-Final OA 3d overdue Pending Sep 15, 2022
17904211 LONG CHAIN CARBON AND CYCLIC AMINO ACIDS SUBSTRATES FOR GENETIC CODE REPROGRAMMING The Board Of Trustees Of The University Of Illinois OLSON, ANDREA STEFFEL 1693 §103 Non-Final OA 43d overdue Pending Aug 12, 2022
17760040 Polyelectrolyte Single Crystal for Proton Conductivity King Abdulaziz City For Scince And Technology (Kacst) ROSWELL, JESSICA MARIE 1767 §102 Final Rejection Pending Aug 03, 2022
17757746 AQUEOUS RECHARGEABLE ZINC BATTERIES Newsouth Innovations Pty Ltd CHUO, TONY SHENG HSIANG 1751 §103 Non-Final OA Pending Jun 20, 2022
17784891 METHOD AND COMPOSITION FOR ENHANCING THE IMMUNE RESPONSE Northwestern University REDDIG, PETER J 1646 §103 Non-Final OA 38d overdue Pending Jun 13, 2022
17838428 MODULATION OF UBIQUITIN CARBOXY-TERMINAL HYDROLASE LIGASE 1 (UCHL1) EXPRESSION FOR TREATING NEUROLOGICAL DISEASE, DISORDERS, AND INJURIES ASSOCIATED WITH UPPER MOTOR NEURONS Northwestern University CORDAS, EMILY ANN 1632 §102 Final Rejection 13d Pending Jun 13, 2022
17778340 FLUID MECHANICS-BASED ANALYSIS TOOL TO ESTIMATE FLOW DATA FROM PLANIMETRY CATHETER DATA Northwestern University ROBERTS, ANNA L 3791 §103 Non-Final OA 27d Pending May 19, 2022
17606441 STABILIZATION AND PRESERVATION OF IN VITRO TRANSCRIPTION REACTIONS President and Fellows of Harvard College LEE, HOI YAN NMN 1693 §103 Non-Final OA 22d overdue Pending Oct 25, 2021
17503057 ANTI-POLYETHYLENE GLYCOL (PEG) ANTIBODY MOUSE MODEL FOR RIGOROUS ASSESSMENT OF PEG-BASED THERAPIES: ADJUVANT-FREE INDUCTION MODEL Northwestern University WEHBE, ANNE MARIE SABRINA 1634 §102 Final Rejection 14d Pending Oct 15, 2021
17594119 MARKERS OF EFFICACY OF TOPOISOMERASE POISONS Northwestern University KENNEDY, SARAH JANE 1682 §103 Non-Final OA 25d overdue Pending Oct 04, 2021

Managing Quarles & Brady LLP (Northwestern)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month